EPHA2 and cholangiocarcinoma: Regarding CCA, EphA2 is seen to play an important role in its pathogenesis, since EphA2 is overexpressed in response to growth factors, leading to activation of the mammalian target of rapamycin complex 1 (mTORC1) and extracellular signal-regulated kinase (ERK) pathways (Figure 1).